Welcome to Drug and Therapeutics Bulletin (DTB)
For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals.
DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship.
DTB Calls for reform of NHS Prescription Charges
The NHS prescription charge has long been a contentious issue. This charge has been abolished in Scotland, Wales and Northern Ireland, leaving patients in England alone in the UK in having to pay for their prescriptions. Although there are many exemptions from the prescription charge, these appear illogical and unfair. DTB believes that the prescription charge is a poorly conceived, manifestly unfair tax and is in need of reform.
Upcoming DTB Topics
Upcoming DTB topics include:
Apremilast – a new DMARD
Melatonin for sleep disorders in children
Breathing exercises for asthma
Ivermectin for rosacea
Ankle joint replacement
An update on glaucoma
Naloxegol for opioid induced constipation
Read educational articles published in DTB and then test your knowledge on BMJ Learning:
DTB scans sources of information on treatments, disease management and other healthcare topics. This information is presented in a succinct, contextualised summary to keep our readers up-to-date - DTB Select